The week at Retraction Watch featured the retraction of a paper from Yale on ketamine and depression, a retraction for Carlo Croce, and a discussion of when a citation may not be enough. Here’s what was happening elsewhere:
On April 17th, Mathieu Bollen, a researcher at KU Leuven in Belgium, received a notice from PubPeer: A paper he had published in 2013 appeared to have data duplications. The article, “Maternal Embryonic Leucine Zipper Kinase (MELK) Reduces Replication Stress in Glioblastoma Cells,” published in the Journal of Biological Chemistry, offered an explanation for why … Continue reading Author cops to “randomly” choosing data for figures in paper, colleagues say
A psychiatry journal has retracted a 2011 paper exploring the use of ketamine to treat patients with severe depression following an investigation at Yale University. According to the retraction notice, Yale determined that the paper, published in the International Journal of Neuropsychopharmacology, did not accurately describe the research. But the study’s lead author, Gregory Larkin, … Continue reading Ketamine-depression paper retracted following investigation at Yale
The week at Retraction Watch featured the revocation of a PhD, a questionable way to boost university rankings, and a look at what editors should do when a researcher known to have committed misconduct submits a new manuscript. Here’s what was happening elsewhere:
In December of last year, Chris Surridge found himself in a situation not uncommon to journal editors: A researcher who had been found to have committed misconduct had submitted a manuscript to the journal Surridge edits, Nature Plants. Retraction Watch readers may recall the name of the corresponding author, Patrice Dunoyer, who has had five papers … Continue reading What should a journal do when a scientist who committed misconduct submits a new paper?
A biologist at the University of Basel is retracting two papers, citing data manipulation uncovered during an institutional investigation. That investigation has already led to the retraction of a paper in Science Translational Medicine by some of the same authors earlier this year. The two latest retractions, in the Journal of Biological Chemistry (JBC), share … Continue reading “Data had been manipulated,” again: Swiss probe prompts two more retractions
The week at Retraction Watch featured the retraction of a paper linked to vaccines, and what happens when a journal retracts 107 papers at once. Here’s what was happening elsewhere:
A company that indexes journals — thereby assigning them impact factors — has chosen to delist a cancer journal after it retracted 107 papers earlier this year for faked peer reviews. Starting July 19, anything published by Tumor Biology will not be indexed in Web of Science, part of Clarivate Analytics (formerly part of Thomson … Continue reading When a journal retracts 107 papers for fake reviews, it pays a price
The week at Retraction Watch featured a look at publishing bounties around the world, and the story of how the “right to be forgotten” law had led to a retraction. Here’s what was happening elsewhere:
A trove of internal documents from Monsanto, recently unsealed in a lawsuit against the agricultural biotech giant, has revealed the firm’s role in the knotty tale of a paper from the lab of a scientist known for his stance against genetically modified organisms (GMOs). That paper is “Long term toxicity of a Roundup herbicide and … Continue reading Unearthed emails: Monsanto connected to campaign to retract GMO paper